SCHEMBL7957664

SCHEMBL7957664

Cc1ccc(C2CCN(CCCc3nnc4n3CCCCC4)CC2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
CHRM2 P08172 1/20 0.48
HTR1A P08908 1/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA1D P25100 1/20 0.48
HTR2A P28223 1/20 0.48
HTR2C P28335 1/20 0.48
SLC6A4 P31645 1/20 0.48
ADRA1A P35348 1/20 0.48
DRD3 P35462 1/20 0.48
HTR2B P41595 1/20 0.48
HPGD P15428 1/20 0.47
GFER P55789 1/20 0.45
MAPT P10636 1/20 0.43
HRH1 P35367 1/20 0.42
TSHR P16473 1/20 0.42
MAPK1 P28482 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7957361 0.89 DRD2 (0.48) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7957315 0.89 LMNA (0.51) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7959702 0.89 TSHR (0.51) KDM4EL3MBTL1CHRM2HTR1AADRA2A
SCHEMBL7949249 0.89 DRD2 (0.51) L3MBTL1CHRM2HTR1AADRA2AADRA2B
Hydrochloric Acid SCHEMBL8570980 0.88 DRD2 (0.47) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7959711 0.83 SLC6A4 (0.51) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7959264 0.82 LMNA (0.53) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7959555 0.82 LMNA (0.46) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7964136 0.81 GAA (0.52) CHRM2HTR1AADRA2AADRA2BADRA1D
SCHEMBL7964120 0.81 CHRM2 (0.42) KDM4EL3MBTL1CHRM2HTR1AADRA2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6187774-B1 N-PIPERAZINYLALKYLINDAZOLE DERIVATIVES; PSYCHOLOGICAL DISORDERS, SCHIZOPHRENIA; SIDE EFFECT REDUCTION YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 2001-02-13 US disclosed
EP-0885883-A1 FUSED HETEROCYCLIC COMPOUNDS AND PHARMACEUTICAL APPLICATIONS THEREOF YOSHITOMI PHARMACEUTICAL INDUSTRIES, LTD. (JP) 1998-12-23 EP disclosed